Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning

被引:1711
作者
Coudray, Nicolas [1 ,2 ]
Ocampo, Paolo Santiago [3 ]
Sakellaropoulos, Theodore [4 ]
Narula, Navneet [3 ]
Snuderl, Matija [3 ]
Fenyo, David [5 ,6 ]
Moreira, Andre L. [3 ,7 ]
Razavian, Narges [8 ,9 ]
Tsirigos, Aristotelis [1 ,3 ]
机构
[1] NYU, Sch Med, Appl Bioinformat Labs, New York, NY 10003 USA
[2] NYU, Sch Med, Dept Cell Biol, Skirball Inst, New York, NY 10016 USA
[3] NYU, Sch Med, Dept Pathol, New York, NY 10003 USA
[4] Natl Tech Univ Athens, Sch Mech Engn, Zografos, Greece
[5] NYU, Sch Med, Inst Syst Genet, New York, NY USA
[6] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA
[7] NYU, Ctr Biospecimen Res & Dev, New York, NY USA
[8] NYU, Sch Med, Dept Populat Hlth, New York, NY 10003 USA
[9] NYU, Sch Med, Ctr Healthcare Innovat & Delivery Sci, New York, NY 10003 USA
关键词
TARGETED THERAPY; NEURAL-NETWORKS; EGFR MUTATION; LKB1; ADENOCARCINOMAS; INACTIVATION; SOCIETY; PROMISE; KRAS;
D O I
10.1038/s41591-018-0177-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Visual inspection of histopathology slides is one of the main methods used by pathologists to assess the stage, type and subtype of lung tumors. Adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) are the most prevalent subtypes of lung cancer, and their distinction requires visual inspection by an experienced pathologist. In this study, we trained a deep convolutional neural network (inception v3) on whole-slide images obtained from The Cancer Genome Atlas to accurately and automatically classify them into LUAD, LUSC or normal lung tissue. The performance of our method is comparable to that of pathologists, with an average area under the curve (AUC) of 0.97. Our model was validated on independent datasets of frozen tissues, formalin-fixed paraffin-embedded tissues and biopsies. Furthermore, we trained the network to predict the ten most commonly mutated genes in LUAD. We found that six of them-STK11, EGFR, FAT1, SETBP1, KRAS and TP53-can be predicted from pathology images, with AUCs from 0.733 to 0.856 as measured on a held-out population. These findings suggest that deep-learning models can assist pathologists in the detection of cancer subtype or gene mutations. Our approach can be applied to any cancer type, and the code is available at https://github.com/ncoudray/DeepPATH.
引用
收藏
页码:1559 / +
页数:11
相关论文
共 67 条
  • [41] Parums DV, 2014, DRUG TODAY, V50, P503, DOI [10.1358/dot.2014.50.07.2185913, 10.1358/dot.2014.50.7.2185913]
  • [42] Pedregosa F., 2011, J. Mach. Learn. Res.
  • [43] Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer
    Pérez-Soler, R
    Chachoua, A
    Hammond, LA
    Rowinsky, EK
    Huberman, M
    Karp, D
    Rigas, J
    Clark, GM
    Santabàrbara, P
    Bonomi, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) : 3238 - 3247
  • [44] Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population
    Rodig, Scott J.
    Mino-Kenudson, Mari
    Dacic, Sanja
    Yeap, Beow Y.
    Shaw, Alice
    Barletta, Justine A.
    Stubbs, Hannah
    Law, Kenny
    Lindeman, Neal
    Mark, Eugene
    Janne, Pasi A.
    Lynch, Thomas
    Johnson, Bruce E.
    Iafrate, A. John
    Chirieac, Lucian R.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (16) : 5216 - 5223
  • [45] Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659
  • [46] Schaumberg A.J., 2016, H E STAINED WHOLE SL, DOI [DOI 10.1101/064279, 10.1101/064279]
  • [47] Deep learning in neural networks: An overview
    Schmidhuber, Juergen
    [J]. NEURAL NETWORKS, 2015, 61 : 85 - 117
  • [48] Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
    Sequist, Lecia V.
    Waltman, Belinda A.
    Dias-Santagata, Dora
    Digumarthy, Subba
    Turke, Alexa B.
    Fidias, Panos
    Bergethon, Kristin
    Shaw, Alice T.
    Gettinger, Scott
    Cosper, Arjola K.
    Akhavanfard, Sara
    Heist, Rebecca S.
    Temel, Jennifer
    Christensen, James G.
    Wain, John C.
    Lynch, Thomas J.
    Vernovsky, Kathy
    Mark, Eugene J.
    Lanuti, Michael
    Iafrate, A. John
    Mino-Kenudson, Mari
    Engelman, Jeffrey A.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (75)
  • [49] LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin
    Shackelford, David B.
    Abt, Evan
    Gerken, Laurie
    Vasquez, Debbie S.
    Seki, Atsuko
    Leblanc, Mathias
    Wei, Liu
    Fishbein, Michael C.
    Czernin, Johannes
    Mischel, Paul S.
    Shaw, Reuben J.
    [J]. CANCER CELL, 2013, 23 (02) : 143 - 158
  • [50] Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI [10.1146/annurev-bioeng-071516-044442, 10.1146/annurev-bioeng-071516044442]